Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail
-

Slides for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

 

Morning Session

FDA

  FDA Core Presentation, Pixuvri (Pixantrone), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 482KB)

 

Cell Therapeutics, Inc

CTI Core Presentation, Pixuvri (Pixantrone), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 720KB)

CTI Backup Presentation, Pixuvri (Pixantrone), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.13MB)

 

 

 Afternoon Session

FDA

  FDA Core Presentation, Omacetaxine (Omapro), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 553KB)

 

ChemGenex Pharmaceuticals, Inc

  CGPI Core Presentation, Omacetaxine (Omapro), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.01MB)

CGPI Backup Presentation, Omacetaxine (Omapro), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 59.6KB)

-
-